Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001209191-23-030370 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-15 | RXRX | Gibson Christopher | CEO, Dir | F - Tax | $5.60 | -11.7K | 941.6K | -1% | -$65.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-15 | F | D | 11,661 | $5.60 | 941,564 | D | — | — |